Concepedia

Alan L. Mendrala

AL

Statistics

Publications

15

Citations

1.3K

H-Index

15

Active since

1979

Affiliations

Dow Chemical (United States)(Current)

Dow Chemical (India)

Vanderbilt University

Research Triangle Park Foundation

Michigan State University

Alan L. Mendrala is an author at Dow Chemical (United States) specializing in pharmacy, pharmacokinetics, and drug disposition.

Publications per year

1979–2005

15

Publications

15

DNA excision-repair processes in human cells can eliminate the cytotoxic and mutagenic consequences of ultraviolet irradiation

Veronica M. Maher, Delia J. Dorney, Alan L. Mendrala et al. · Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis · 1979 · 244 citations

, , +17

Development of a physiologically based pharmacokinetic model for chloroform

Richard Corley, Alan L. Mendrala, F.A. Smith et al. · Toxicology and Applied Pharmacology · 1990 · 181 citations

, , +8

In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically based pharmacokinetic models

Richard H. Reitz, Alan L. Mendrala, F. Peter Guengerich · Toxicology and Applied Pharmacology · 1989 · 138 citations

, , +9

Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling

Richard H. Reitz, Alan L. Mendrala, Richard Corley et al. · Toxicology and Applied Pharmacology · 1990 · 118 citations

, , +16

A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man

Gy.A. Csanády, Alan L. Mendrala, R.J. Nolan et al. · Archives of Toxicology · 1994 · 107 citations

, , +7

1–5 of 15